Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 4
1(50.0%)
2Total
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05935293Phase 4Not Yet Recruiting

Dexmedetomidine and Kidney Transplantation

Role: lead

NCT06357455Not ApplicableNot Yet Recruiting

Platelet Count and Function After Usage of Two Different Cell Saver Devices During Liver Transplant Surgery

Role: lead

NCT04249674Unknown

Impact of CYP2D6 Genetic Polymorphisms on the Vulnerability to Drug-drug Interactions With Tramadol

Role: collaborator

All 3 trials loaded